View Item 

Show simple item record

The SPLIT Research Agenda 2013
dc.contributor.authorAlonso, Estella M.en_US
dc.contributor.authorNg, Vicky L.en_US
dc.contributor.authorAnand, Ravinderen_US
dc.contributor.authorAnderson, Christopher D.en_US
dc.contributor.authorEkong, Udeme D.en_US
dc.contributor.authorFredericks, Emily M.en_US
dc.contributor.authorFuruya, Katryn N.en_US
dc.contributor.authorGupta, Nitika A.en_US
dc.contributor.authorLerret, Stacee M.en_US
dc.contributor.authorSundaram, Shikhaen_US
dc.contributor.authorTiao, Gregen_US
dc.date.accessioned2013-07-08T17:45:44Z
dc.date.available2014-10-06T19:17:44Zen_US
dc.date.issued2013-08en_US
dc.identifier.citationAlonso, Estella M.; Ng, Vicky L.; Anand, Ravinder; Anderson, Christopher D.; Ekong, Udeme D.; Fredericks, Emily M.; Furuya, Katryn N.; Gupta, Nitika A.; Lerret, Stacee M.; Sundaram, Shikha; Tiao, Greg (2013). "The SPLIT Research Agenda 2013." Pediatric Transplantation 17(5): 412-422. <http://hdl.handle.net/2027.42/98814>en_US
dc.identifier.issn1397-3142en_US
dc.identifier.issn1399-3046en_US
dc.identifier.urihttps://hdl.handle.net/2027.42/98814
dc.description.abstractThis review focuses on active clinical research in pediatric liver transplantation with special emphasis on areas that could benefit from studies utilizing the SPLIT infrastructure and data repository. Ideas were solicited by members of the SPLIT Research Committee and sections were drafted by members of the committee with expertise in those given areas. This review is intended to highlight priorities for clinical research that could successfully be conducted through the SPLIT collaborative and would have significant impact in pediatric liver transplantation.en_US
dc.publisherNational Cancer Instituteen_US
dc.publisherWiley Periodicals, Inc.en_US
dc.subject.otherOutcomeen_US
dc.subject.otherLong‐Term Resultsen_US
dc.subject.otherIndicationsen_US
dc.subject.otherPediatric Liver Transplantationen_US
dc.subject.otherHealth Outcomesen_US
dc.titleThe SPLIT Research Agenda 2013en_US
dc.typeArticleen_US
dc.rights.robotsIndexNoFollowen_US
dc.subject.hlbsecondlevelPediatricsen_US
dc.subject.hlbtoplevelHealth Sciencesen_US
dc.description.peerreviewedPeer Revieweden_US
dc.identifier.pmid23718800en_US
dc.description.bitstreamurlhttp://deepblue.lib.umich.edu/bitstream/2027.42/98814/1/petr12090.pdf
dc.identifier.doi10.1111/petr.12090en_US
dc.identifier.sourcePediatric Transplantationen_US
dc.identifier.citedreferenceViner R. Transition from paediatric to adult care. Bridging the gaps or passing the buck? Arch Dis Child 1999: 81: 271 – 275.en_US
dc.identifier.citedreferenceBrowne M, Sher D, Grant D, et al. Survival after liver transplantation for hepatoblastoma: A 2‐center experience. J Pediatr Surg 2008: 43: 1973 – 1981.en_US
dc.identifier.citedreferenceSundaram SS, Alonso EM, Zeitler P, Yin W, Anand R. Obesity after pediatric liver transplantation: Prevalence and risk factors. J Pediatr Gastroenterol Nutr 2012 Jun 28: PMID: 22744193.en_US
dc.identifier.citedreferenceLiem RI, Anand R, Yin W, Alonso EM. Risk factors for chronic anemia in pediatric orthotopic liver transplantation: Analysis of data from the SPLIT registry. Pediatr Transplant 2012: 16: 137 – 143.en_US
dc.identifier.citedreferenceMcLin VA, Anand R, Daniels SR, Yin W, Alonso EM. Blood pressure elevation in long‐term survivors of pediatric liver transplantation. Am J Transplant 2012: 12: 183 – 190.en_US
dc.identifier.citedreferenceHathout E, Alonso E, Anand R, et al. Post‐transplant diabetes mellitus in pediatric liver transplantation. Pediatr Transplant 2009: 13: 599 – 605.en_US
dc.identifier.citedreferenceMcDiarmid SV, Anand R, Martz K, Millis MJ, Mazariegos G. A multivariate analysis of pre‐, peri‐, and post‐transplant factors affecting outcome after pediatric liver transplantation. Ann Surg 2011: 254: 145 – 154.en_US
dc.identifier.citedreferenceLa Greca AM, Bearman KJ. Adherence to pediatric treatment regimens. In: Roberts MC, ed. Handbook of Pediatric Psychology. New York: The Guilford Press, 2003: pp. 119 – 140.en_US
dc.identifier.citedreferenceShaw R. Treatment adherence in adolescents: Development and psychopathology. Clin Child Psychol Psychiatry 2001: 6: 137 – 150.en_US
dc.identifier.citedreferenceSuris JC, Michaud PA, Viner R. The adolescent with a chronic condition. Part I: Developmental issues. Arch Dis Child 2004: 89: 938 – 942.en_US
dc.identifier.citedreferenceDew MA, Dabbs AD, Myaskovsky L, et al. Meta‐analysis of medical regimen adherence outcomes in pediatric solid organ transplantation. Transplantation 2009: 88: 736 – 746.en_US
dc.identifier.citedreferenceDobbels F, Van Damme‐Lombaert R, Vanhaecke J, De Geest S. Growing pains: Non‐adherence with the immunosuppressive regimen in adolescent transplant recipients. Pediatr Transplant 2005: 9: 381 – 390.en_US
dc.identifier.citedreferenceKahana SY, Frazier TW, Drotar D. Preliminary quantitative investigation of predictors of treatment non‐adherence in pediatric transplantation: A brief report. Pediatr Transplant 2008: 12: 656 – 660.en_US
dc.identifier.citedreferenceFredericks EM, Lopez MJ, Magee JC, Shieck V, Opipari‐Arrigan L. Psychological functioning, nonadherence and health outcomes after pediatric liver transplantation. Am J Transplant 2007: 7: 1974 – 1983.en_US
dc.identifier.citedreferenceFredericks EM, Magee JC, Opipari‐Arrigan L, Shieck V, Well A, Lopez MJ. Adherence and health‐related quality of life in adolescent liver transplant recipients. Pediatr Transplant 2008: 12: 289 – 299.en_US
dc.identifier.citedreferenceGriffin KJ, Elkin TD. Non‐adherence in pediatric transplantation: A review of the existing literature. Pediatr Transplant 2001: 5: 246 – 249.en_US
dc.identifier.citedreferencePinsky BW, Takemoto SK, Lentine KL, Burroughs TE, Schnitzler MA, Salvalaggio PR. Transplant outcomes and economic costs associated with patient noncompliance to immunosuppression. Am J Transplant 2009: 9: 2597 – 2606.en_US
dc.identifier.citedreferenceWatson AR. Non‐compliance and transfer from paediatric to adult transplant unit. Pediatr Nephrol 2000: 14: 469 – 472.en_US
dc.identifier.citedreferenceAnnunziato RA, Emre S, Shneider B, Barton C, Dugan CA, Shemesh E. Adherence and medical outcomes in pediatric liver transplant recipients who transition to adult services. Pediatr Transplant 2007: 11: 608 – 614.en_US
dc.identifier.citedreferenceFine RN, Becker Y, De Geest S, et al. Nonadherence consensus conference summary report. Am J Transplant 2009: 9: 35 – 41.en_US
dc.identifier.citedreferenceBucuvalas JC, Ryckman FC, Arya G, et al. A novel approach to managing variation: Outpatient therapeutic monitoring of calcineurin inhibitor blood levels in liver transplant recipients. J Pediatr 2005: 146: 744 – 750.en_US
dc.identifier.citedreferenceShemesh E, Shneider BL, Savitzky JK, et al. Medication adherence in pediatric and adolescent liver transplant recipients. Pediatrics 2004: 113: 825 – 832.en_US
dc.identifier.citedreferenceStuber ML, Shemesh E, Seacord D, Washington J III, Hellemann G, McDiarmid S. Evaluating non‐adherence to immunosuppressant medications in pediatric liver transplant recipients. Pediatr Transplant 2008: 12: 284 – 288.en_US
dc.identifier.citedreferenceBlum RW, Garell D, Hodgman CH, et al. Transition from child‐centered to adult health‐care systems for adolescents with chronic conditions. A position paper of the Society for Adolescent Medicine. J Adolesc Health 1993: 14: 570 – 576.en_US
dc.identifier.citedreferenceKennedy A, Sawyer S. Transition from pediatric to adult services: Are we getting it right? Curr Opin Pediatr 2008: 20: 403 – 409.en_US
dc.identifier.citedreferenceSawyer SM, Blair S, Bowes G. Chronic illness in adolescents: Transfer or transition to adult services? J Paediatr Child Health 1997: 33: 88 – 90.en_US
dc.identifier.citedreferenceKieckhefer GM, Trahms CM. Supporting development of children with chronic conditions: From compliance toward shared management. Pediatr Nurs 2000: 26: 354 – 363.en_US
dc.identifier.citedreferenceWatson AR. Problems and pitfalls of transition from paediatric to adult renal care. Pediatr Nephrol 2005: 20: 113 – 117.en_US
dc.identifier.citedreferenceFredericks EM, Dore‐Stites D, Well A, et al. Assessment of transition readiness skills and adherence in pediatric liver transplant recipients. Pediatr Transplant 2010: 14: 944 – 953.en_US
dc.identifier.citedreferenceMcDonagh JE, Hackett J. Interrelationship of self‐management and transitional care needs of adolescents with arthritis: Comment on the article by Stinson et al. Arthritis Rheum 2008: 59: 1199 – 1200; author reply 1200–1191.en_US
dc.identifier.citedreferenceFeng S, Goodrich NP, Bragg‐Gresham JL, et al. Characteristics associated with liver graft failure: The concept of a donor risk index. Am J Transplant 2006: 6: 783 – 790.en_US
dc.identifier.citedreferenceSchaubel DE, Sima CS, Goodrich NP, Feng S, Merion RM. The survival benefit of deceased donor liver transplantation as a function of candidate disease severity and donor quality. Am J Transplant 2008: 8: 419 – 425.en_US
dc.identifier.citedreferenceAnderson CD, Turmelle YP, Lowell JA, et al. The effect of recipient‐specific surgical issues on outcome of liver transplantation in biliary atresia. Am J Transplant 2008: 8: 1197 – 1204.en_US
dc.identifier.citedreferenceDiamond IR, Fecteau A, Millis JM, et al. Impact of graft type on outcome in pediatric liver transplantation: A report From Studies of Pediatric Liver Transplantation (SPLIT). Ann Surg 2007: 246: 301 – 310.en_US
dc.identifier.citedreferenceCacciarelli TV, Dvorchik I, Mazariegos GV, et al. An analysis of pretransplantation variables associated with long‐term allograft outcome in pediatric liver transplant recipients receiving primary tacrolimus (FK506) therapy. Transplantation 1999: 68: 650 – 655.en_US
dc.identifier.citedreferenceAnderson CD, Turmelle YP, Darcy M, et al. Biliary strictures in pediatric liver transplant recipients – early diagnosis and treatment results in excellent graft outcomes. Pediatr Transplant 2010: 14: 358 – 363.en_US
dc.identifier.citedreferenceMcLaughlin CC, Baptiste MS, Schymura MJ, Nasca PC, Zdeb MS. Maternal and infant birth characteristics and hepatoblastoma. Am J Epidemiol 2006: 163: 818 – 828.en_US
dc.identifier.citedreferenceBulterys M, Goodman M, Smith M, Jd B. Hepatic tumors. In: Ries LAG, Smith MA, Gurney JG, et al., eds. Cancer Incidence and Survival among Children and Adolescents: United States SEER Program 1975–1995. Bethesda, MD: National Cancer Institute, 1999.en_US
dc.identifier.citedreferencePlaschkes J, Perilongo G, Shafford E, et al. SIOP trial report – overall preliminary results of SIOPEL‐1 for the treatment of hepatoblastoma (HB) with pre‐operative chemotherapy – continuous infusion cisplatin and doxorubicin (PLADO). 1994.en_US
dc.identifier.citedreferenceRoebuck DJ, Aronson D, Clapuyt P, et al. 2005 PRETEXT: A revised staging system for primary malignant liver tumours of childhood developed by the SIOPEL group. Pediatr Radiol 2007: 37: 123 – 132; quiz 249–150.en_US
dc.identifier.citedreferenceSuperina R, Bilik R. Results of liver transplantation in children with unresectable liver tumors. J Pediatr Surg 1996: 31: 835 – 839.en_US
dc.identifier.citedreferenceReyes JD, Carr B, Dvorchik I, et al. Liver transplantation and chemotherapy for hepatoblastoma and hepatocellular cancer in childhood and adolescence. J Pediatr 2000: 136: 795 – 804.en_US
dc.identifier.citedreferenceAl‐Qabandi W, Jenkinson HC, Buckels JA, et al. Orthotopic liver transplantation for unresectable hepatoblastoma: A single center's experience. J Pediatr Surg 1999: 34: 1261 – 1264.en_US
dc.identifier.citedreferenceZsiros J, Maibach R, Shafford E, et al. Successful treatment of childhood high‐risk hepatoblastoma with dose‐intensive multiagent chemotherapy and surgery: Final results of the SIOPEL‐3HR study. J Clin Oncol 2010: 28: 2584 – 2590.en_US
dc.identifier.citedreferenceOtte JB, Pritchard J, Aronson DC, et al. Liver transplantation for hepatoblastoma: Results from the International Society of Pediatric Oncology (SIOP) study SIOPEL‐1 and review of the world experience. Pediatr Blood Cancer 2004: 42: 74 – 83.en_US
dc.identifier.citedreferencePimpalwar AP, Sharif K, Ramani P, et al. Strategy for hepatoblastoma management: Transplant versus nontransplant surgery. J Pediatr Surg 2002: 37: 240 – 245.en_US
dc.identifier.citedreferenceAvila L, Encinas J, Leal N, et al. Liver transplantation for malignant tumors in children. Cir Pediatr 2007: 20: 189 – 193.en_US
dc.identifier.citedreferenceOtte JB. Progress in the surgical treatment of malignant liver tumors in children. Cancer Treat Rev 2010: 36: 360 – 371.en_US
dc.identifier.citedreferenceMalogolowkin MH, Katzenstein H, Krailo MD, et al. Intensified platinum therapy is an ineffective strategy for improving outcome in pediatric patients with advanced hepatoblastoma. J Clin Oncol 2006: 24: 2879 – 2884.en_US
dc.identifier.citedreferenceWarmann S, Fuchs J. Drug resistance in hepatoblastoma. Curr Pharm Biotechnol 2007: 8: 93 – 97.en_US
dc.identifier.citedreferenceOtte JB, Meyers R. PLUTO first report. Pediatr Transplant 2010: 14: 830 – 835.en_US
dc.identifier.citedreferenceDarbari A, Sabin KM, Shapiro CN, Schwarz KB. Epidemiology of primary hepatic malignancies in U.S. children. Hepatology 2003: 38: 560 – 566.en_US
dc.identifier.citedreferenceZimmermann A. Hepatoblastoma with cholangioblastic features (‘cholangioblastic hepatoblastoma’) and other liver tumors with bimodal differentiation in young patients. Med Pediatr Oncol 2002: 39: 487 – 491.en_US
dc.identifier.citedreferenceZimmermann A. The emerging family of hepatoblastoma tumours: From ontogenesis to oncogenesis. Eur J Cancer 2005: 41: 1503 – 1514.en_US
dc.identifier.citedreferenceKatzenstein HM, Krailo MD, Malogolowkin MH, et al. Hepatocellular carcinoma in children and adolescents: Results from the Pediatric Oncology Group and the Children's Cancer Group intergroup study. J Clin Oncol 2002: 20: 2789 – 2797.en_US
dc.identifier.citedreferenceCzauderna P, Mackinlay G, Perilongo G, et al. Hepatocellular carcinoma in children: Results of the first prospective study of the International Society of Pediatric Oncology group. J Clin Oncol 2002: 20: 2798 – 2804.en_US
dc.identifier.citedreferenceMazzaferro V, Regalia E, Doci R, et al. Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis. N Engl J Med 1996: 334: 693 – 699.en_US
dc.identifier.citedreferenceProkurat A, Kluge P, Kosciesza A, Perek D, Kappeler A, Zimmermann A. Transitional liver cell tumors (TLCT) in older children and adolescents: A novel group of aggressive hepatic tumors expressing beta‐catenin. Med Pediatr Oncol 2002: 39: 510 – 518.en_US
dc.identifier.citedreferenceBeaunoyer M, Vanatta JM, Ogihara M, et al. Outcomes of transplantation in children with primary hepatic malignancy. Pediatr Transplant 2007: 11: 655 – 660.en_US
dc.identifier.citedreferenceIsmail H, Broniszczak D, Kalicinski P, et al. Liver transplantation in children with hepatocellular carcinoma. Do Milan criteria apply to pediatric patients? Pediatr Transplant 2009: 13: 682 – 692.en_US
dc.identifier.citedreferenceGupta AA, Gerstle JT, Ng V, et al. Critical review of controversial issues in the management of advanced pediatric liver tumors. Pediatr Blood Cancer 2011: 56: 1013 – 1018.en_US
dc.identifier.citedreferenceMazariegos GV, Sindhi R, Thomson AW, Marcos A. Clinical tolerance following liver transplantation: Long term results and future prospects. Transpl Immunol 2007: 17: 114 – 119.en_US
dc.identifier.citedreferenceKoshiba T, Li Y, Takemura M, et al. Clinical, immunological, and pathological aspects of operational tolerance after pediatric living‐donor liver transplantation. Transpl Immunol 2007: 17: 94 – 97.en_US
dc.identifier.citedreferenceTakatsuki M, Uemoto S, Inomata Y, et al. Weaning of immunosuppression in living donor liver transplant recipients. Transplantation 2001: 72: 449 – 454.en_US
dc.identifier.citedreferenceFeng S, Ekong UD, Lobritto SJ, et al. Complete immunosuppression withdrawal and subsequent allograft function among pediatric recipients of parental living donor liver transplants. JAMA 2012: 307: 283 – 293.en_US
dc.identifier.citedreferenceAnsari MJ, Sayegh MH. Clinical transplantation tolerance: The promise and challenges. Kidney Int 2004: 65: 1560 – 1563.en_US
dc.identifier.citedreferenceDemetris AJ, Lunz JG III, Randhawa P, Wu T, Nalesnik M, Thomson AW. Monitoring of human liver and kidney allograft tolerance: A tissue/histopathology perspective. Transpl Int 2009: 22: 120 – 141.en_US
dc.identifier.citedreferenceEvans HM, Kelly DA, McKiernan PJ, Hubscher S. Progressive histological damage in liver allografts following pediatric liver transplantation. Hepatology 2006: 43: 1109 – 1117.en_US
dc.identifier.citedreferenceScheenstra R, Peeters PM, Verkade HJ, Gouw AS. Graft fibrosis after pediatric liver transplantation: Ten years of follow‐up. Hepatology 2009: 49: 880 – 886.en_US
dc.identifier.citedreferenceAbraham SC, Poterucha JJ, Rosen CB, Demetris AJ, Krasinskas AM. Histologic abnormalities are common in protocol liver allograft biopsies from patients with normal liver function tests. Am J Surg Pathol 2008: 32: 965 – 973.en_US
dc.identifier.citedreferenceEkong UD, Melin‐Aldana H, Seshadri R, et al. Graft histology characteristics in long‐term survivors of pediatric liver transplantation. Liver Transpl 2008: 14: 1582 – 1587.en_US
dc.identifier.citedreferenceMells G, Mann C, Hubscher S, Neuberger J. Late protocol liver biopsies in the liver allograft: A neglected investigation? Liver Transpl 2009: 15: 931 – 938.en_US
dc.identifier.citedreferenceNg VL, Fecteau A, Shepherd R, et al. Outcomes of 5‐year survivors of pediatric liver transplantation: Report on 461 children from a north american multicenter registry. Pediatrics 2008: 122: e1128 – e1135.en_US
dc.identifier.citedreferenceNg VL, Alonso EM, Bucuvalas JC, et al. Health status of children alive 10 years after pediatric liver transplantation performed in the US and Canada: Report of the studies of pediatric liver transplantation experience. J Pediatr 2012: 160: 820 – 826 e823.en_US
dc.identifier.citedreferenceCampbell K, Ng V, Martin S, et al. Glomerular filtration rate following pediatric liver transplantation–the SPLIT experience. Am J Transplant 2010: 10: 2673 – 2682.en_US
dc.identifier.citedreferenceMcDonagh JE, Kelly DA. Trans‐plan‐sition! Transplantation and transition. Pediatr Transplant 2007: 11: 578 – 581.en_US
dc.identifier.citedreferenceCasas‐Melley A, Malatack J, Consolini DJ, et al. Successful liver transplant for unresectable hepatoblastoma. J Pediatr Surg 2007: 42: 184 – 187.en_US
dc.owningcollnameInterdisciplinary and Peer-Reviewed


Files in this item

Name:
petr12090.pdf
Size:
123.9KB
Format:
PDF
View/Open

Show simple item record

Remediation of Harmful Language

The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.

Accessibility

If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.